In this video, Eva Heldin, section manager of antibody application in R&D at Cytiva and shares her view on: - the antibody therapies pipeline - how to ado...

In this presentation, Henrik Ihre outlines some industry drivers to go smarter and faster in process development as well as insights on the evolution of pr...

Bispecific antibodies (bsAbs) have gained increasing interest over recent years because they can bind two antigens, offering unique modes of action compare...

Smart process development is a collection of approaches to improve process outcomes and speed up process development. In this video, John Scibetta, Advanc...

Membrane proteins are in general very challenging to study as activity and function are easily lost when the protein is extracted from the membrane. But th...

Molecular diversity is increasing rapidly for biotherapeutics, and so also for monoclonal antibodies (mAbs). Of the ever-growing mAb area, variants such as...

We often hear from scientists working with oligonucleotide synthesis that the technical complexity of the process can be a roadblock for some users. Addres...

How do you know if an intensification approach will give you advantages over your current biomanufacturing process, and how do you choose the right one? Yo...

In this webinar we will describe and evaluate different process intensification strategies for the mAb capture step. Strategies will depend on the mode of ...

SPEAKER: Tobias Söderman, Senior Scientist, BioProcess R&D at Cytiva, Uppsala, Sweden WEBINAR ABSTRACT Process robustness and success requires a thorough...